Response Biomed Corp RPBIF

My take

[donofdubai]

My money is still on the table, and that's my bottom line. However, with each passing month my anxiety level has notched up and I have to keep reminding myself about the 'big picture' and the fact that I can handle one more year added to the 7 I've been here so far if that's what it takes. I too, would like to have information about what's happening or not happening regarding the developmental plan - good, neutral, or not so good. Like many here, I too feel a bit in the dark where the plan is concerned. I also feel that if management sets a development plan timeline, they have an obligation and responsibility to update shareholders about the timeline and modify it publicly if necessary. 'No comment' only promotes anxiety and causes shareholder doubt about management's ability to execute the development plan. The net result, is more anxiety. I beleive that is exactly what is happening at this juncture. RBM has a lot of anxious shareholders right now. My take is that the reason for little news is that there just isn't any to release or that news released now would be premature and not in the best interest of the company and shareholders. To date, management's record with shareholders has been credible, so at this point I've no reason to believe that they are not working in my best interest. I beleive they are not advancing the development plan at the previously anticipated rate because they have hit a glitch. I have two theories about what the glitch may be. The first is that they just haven't got the suitor they want. However, my gut feeling is that the execution of the timeline is stalled because of some serious management debate about 'going it alone' vs 'partnering'. Perhaps discussions with potential marketing partners has caused some second thought about what in the long run is best for the company. I'm sure others can come up with other scenerios to explain the delay in the timeline execution. It could be something just as simple as already suggested, like making sure all the 'i's are dotted and the 't's are crossed. More points... I think RBM will require a PP sooner than later I expect Q3 results will not drive a higher share price I think that the share price pull back to 75 cents reflects a general concensus about the above